2019
Research-based versus clinical serum creatinine measurements and the association of acute kidney injury with subsequent kidney function: findings from the Chronic Renal Insufficiency Cohort study
Hsu RK, Hsu CY, McCulloch CE, Yang J, Anderson AH, Chen J, Feldman HI, He J, Liu KD, Navaneethan SD, Porter AC, Rahman M, Tan TC, Wilson FP, Xie D, Zhang X, Go AS, Appel L, Kusek J, Lash J, Rao P, Townsend R. Research-based versus clinical serum creatinine measurements and the association of acute kidney injury with subsequent kidney function: findings from the Chronic Renal Insufficiency Cohort study. Clinical Kidney Journal 2019, 13: 55-62. PMID: 32082553, PMCID: PMC7025351, DOI: 10.1093/ckj/sfz057.Peer-Reviewed Original ResearchAcute kidney injuryChronic Renal Insufficiency CohortSerum creatinine measurementsEGFR declineEGFR slopeKidney injurySerum creatinineKidney functionCreatinine measurementsAssociation of AKIChronic Renal Insufficiency Cohort (CRIC) StudyGlomerular filtration rate (eGFR) trajectoriesChronic kidney disease progressionLarge integrated healthcare delivery systemKidney function testingSubsequent kidney functionKidney disease progressionAbsolute changeIntegrated healthcare delivery systemRoutine clinical careHealthcare delivery systemEGFR lossCohort studyDiabetes statusStrength of association
2015
Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study
Lin J, Khetarpal SA, Terembula K, Reilly MP, Wilson FP. Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study. BMC Nephrology 2015, 16: 130. PMID: 26238454, PMCID: PMC4545861, DOI: 10.1186/s12882-015-0122-5.Peer-Reviewed Original ResearchConceptsMin/yearPenn Diabetes Heart StudyApoC-III levelsBaseline plasmaApoC-IIIGlomerular filtration rate declineSingle-center observational cohortBackgroundChronic kidney diseaseClinical CV diseaseLipid medication usePre-existing CKDCardiovascular risk factorsBaseline plasma levelsGlomerular filtration rateSlope of eGFRAtherogenic lipid fractionsCausal cardiovascular risk factorDiabetes Heart StudyCKD progressionEGFR declineCV diseaseObservational cohortBaseline triglyceridesMedication useMultivariable analysis